Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-04T18:09:52.388Z Has data issue: false hasContentIssue false
  • English
  • Français

The Ethics of Biobanks

Published online by Cambridge University Press:  03 December 2004

SVEN OVE HANSSON
SVEN OVE HANSSON
Affiliation:
Sven Ove Hansson, Ph.D., is Professor of Philosophy at the Royal Institute of Technology (KTH) in Stockholm, Sweden
Get access Rights & Permissions [Opens in a new window]

Extract

Due to modern biochemistry and, in particular, recent developments in genomics, proteomics, and bioinformatics, human samples (organs, tissues, cells, genes, etc.) have become the most important raw materials for advancement in the health sciences. Such material has been at the center of fundamental biomedical research for a long time. What is new is its increased usefulness in research with direct clinical relevance, such as the development of drugs. Because of the larger commercial involvement in such research, this has also led to greater economic interests in human biological material and in the information that can be extracted from it.

Type
SPECIAL SECTION: ETHICAL LIMITS IN HUMAN SUBJECTS RESEARCH
Information
Cambridge Quarterly of Healthcare Ethics , Volume 13 , Issue 4 , October 2004 , pp. 319 - 326
Copyright
© 2004 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)